Ozempic for All?

The Daily vor 10 Monaten

0:00

22:34

Drugs like Ozempic and Zepbound have revolutionized weight loss.
And starting next year, the drugs are going to become more
affordable for Americans because of a deal struck with
pharmaceutical companies by the Trump administration.

Eshe Nelson, who covers economics and business news, explains how
the change has its origins in a huge business blunder from the
creator of Ozempic, Novo Nordisk.

Guest: Eshe Nelson, a reporter for The New York
Times based in London, where she covers economics and business
news.

Background reading:

How Ozempic’s maker lost its shine after creating a wonder
drug.

What Trump’s new drug pricing deal means for people with
obesity.

Photo: Sergei Gapon/Agence France-Presse — Getty Images

For more information on today’s episode,
visit nytimes.com/thedaily. Transcripts of
each episode will be made available by the next workday.

For more information on today’s episode, visit
nytimes.com/thedaily. Transcripts of each
episode will be made available by the next workday.

Subscribe today at nytimes.com/podcasts or on Apple Podcasts,
Spotify and Amazon Music. You can also subscribe via your
favorite podcast app here
https://www.nytimes.com/activate-access/audio?source=podcatcher.
For more podcasts and narrated articles, download The New York
Times app at nytimes.com/app.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for
information about our collection and use of personal data for
advertising.